| Identification | Back Directory | [Name]
5-BROMO-1H-IMIDAZO[4,5-B]PYRAZINE | [CAS]
91225-41-1 | [Synonyms]
5-BROMO-1H-IMIDAZO[4,5-B]PYRAZINE
6-bromo-1H-Imidazo[4,5-b]pyrazine
5-bromo-3H-imidazo[4,5-b]pyrazine
1H-Imidazo[4,5-b]pyrazine, 6-bromo- | [EINECS(EC#)]
604-604-1 | [Molecular Formula]
C5H3BrN4 | [MDL Number]
MFCD10000782 | [MOL File]
91225-41-1.mol | [Molecular Weight]
199.01 |
| Chemical Properties | Back Directory | [Melting point ]
>188°C | [Boiling point ]
249.2±50.0 °C(Predicted) | [density ]
2.28±0.1 g/cm3(Predicted) | [storage temp. ]
-20°C, Inert atmosphere | [solubility ]
Chloroform (Slightly, Sonicated), DMSO (Slightly) | [form ]
Solid | [pka]
3.98±0.20(Predicted) | [color ]
Light Beige to Beige |
| Hazard Information | Back Directory | [Synthesis]
(b) 5-Bromo-2,3-diaminopyrazine (7.8 g, 41.3 mmol, 1 equiv) was added to a 250 mL reaction vial. 80 mL of N,N-dimethylformamide (DMF) was added with continuous stirring to dissolve 5-bromo-2,3-diaminopyrazine. Subsequently, triethyl orthoformate (7.34 g, 49.5 mmol, 1.2 eq.) and 20 mL of formic acid were added dropwise (at a rate of about 1 drop/second). The reaction mixture was heated to reflux and maintained under nitrogen protection for 24 hours (the reaction was monitored by thin layer chromatography (TLC) until the feedstock was essentially consumed). Upon completion of the reaction, the solvent was removed by distillation under reduced pressure and the residue was dissolved in methanol. Finally, purification by silica gel column chromatography afforded 5 g of 5-bromo-1H-imidazo[4,5-b]pyrazine. | [References]
[1] Patent: CN108395436, 2018, A. Location in patent: Paragraph 0010; 0013 |
|
| Company Name: |
J & K SCIENTIFIC LTD.
|
| Telephone: |
18210857532 18210857532 |
| Website: |
https://www.jkchemical.com |
| Company Name: |
Bide Pharmatech Ltd.
|
| Telephone: |
400-1647117 13681763483 |
| Website: |
https://www.bidepharm.com/ |
|